Therapies and Vaccine Development for Emerging and Re emerging Diseases

The emergence of the SARS-CoV-2/COVID-19 pandemic has exposed our continued susceptibility to microbial pathogens and gaps in our therapeutic arsenal. In this webinar, the speakers illustrated the concept of bench-to-bedside research by collectively laying out the avenues necessary for vaccines/therapeutics to progress from pre-clinical work to patients.